The SEC is charging a chemist for the FDA with insider trading. Basically, they say that Cheng Yi Liang knew about upcoming drug decisions and then traded ahead of them.
The FDA even produced this trade chart, going back to 2006, explaining the trades.
NOW WATCH: Money & Markets videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.